Clinic Software
NanoCure AI
Building intelligent platforms for biological analysis, clinical decision support, and next-generation therapeutic development.
About
NanoCure AI is a Texas-based oncology MedTech company building cellular-intelligence systems for hematologic malignancies, blood disorders, and future extracorporeal intervention. Our platform starts with software: a hardware-agnostic Morphologic Classification System for stained blood smear images and a Flow Cytometry FCS Review workflow for.fcs files. Together, these tools generate structured per-cell outputs, reviewable overlays, candidate populations, QC context, and downloadable evidence for pathologist review. We have moved beyond lab-grown AML cell-line validation and are now testing recent de-identified primary human patient slides through Huntsman Cancer Institute, including AML and B-ALL material. Our long-term therapeutic program is a morphology-guided extracorporeal device platform that combines microscopy, AI, fluidics, embedded control, and future nanotechnology-enabled approaches to identify and process abnormal cells outside the body. NanoCure AI is building more than one product. We are building a cell-intelligence company: diagnostics first, evidence generation next, and therapeutic intervention as the long-term goal.
Product
- Value proposition
- Precision medicine platforms that connect biological data, clinical interpretation, and therapeutic development to enable structured, scalable, and actionable decision-making in disease analysis and treatment.
- Target customers
- research institutions, biotech partners, clinical researchers, healthcare organizations
Founders
- Colin LeMahieu
- Dmitry Schetnikovich
- Patricja Pienkowski
Categories
Products
Key features
Technologies
Partnerships
Investors
News
- Cheryl Danley - Head of People & Impact at NanoCure AI R&D... · 2025-08-30T00:00:00.000Z
- NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics · 2025-06-19T12:13:00.000Z
- NeuralCure AI Announces Breakthrough in AI-Powered Healthcare, Completing Decades of Medical Research in Moments · 2025-02-14T13:21:00.000Z
- Novartis Cyprus and Cyprus Seeds’ Teams on Strategic Exchange in Health and MedTech! - Cyprus Seeds · 2025-07-25T11:13:50.000Z
- Cyprus Seeds Drives Research Commercialisation Progress with Notable Achievements — Explained (2025) · 2025-10-31T07:30:00.000Z
- NeuralCure AI Launches the First Diagnostic and Digital Twin OS for Preventative Care Clinics · 2025-06-20T13:31:39.000Z
